Bausch Health Companies Inc.https://pcaobus.org/form-ap-filings/35818/35818Bausch Health Companies Inc.358183/20/2019 3:13:13 PM20187ac5c743-aa26-4fca-8da5-61f31e61f1c9238PricewaterhouseCoopers LLP716521Bausch Health Companies Inc.885590BHC; BHC.0023800326Mark David Bode0023800326271#^#1362PricewaterhouseCoopers LLP#^#PricewaterhouseCoopers Polska spółka z ograniczoną odpowiedzialnością Audyt sp.k.True
Bausch Health Companies Inc.https://pcaobus.org/form-ap-filings/28959/28959Bausch Health Companies Inc.289598/27/2018 10:35:33 AM201756318de9-c27c-48c7-aa6d-7b872c98cdae238PricewaterhouseCoopers LLP716521Bausch Health Companies Inc.885590BHC; BHC.0023800326Mark David Bode0023800326True
Valeant Pharmaceuticals International, Inc.https://pcaobus.org/form-ap-filings/20436/20436Valeant Pharmaceuticals International, Inc.204363/26/2018 4:03:39 PM20172ca3378a-e218-4cef-82ca-38afa7ccf5e1238PricewaterhouseCoopers LLP45820Valeant Pharmaceuticals International, Inc.885590BHC; BHC.0023800326Mark David Bode0023800326True
Warner Chilcott Ltdhttps://pcaobus.org/form-ap-filings/1447/1447Warner Chilcott Ltd14473/7/2017 8:00:48 AM201692998ad6-220e-4bd0-b1f1-fb9d52db0621238PricewaterhouseCoopers LLP599699Warner Chilcott Ltd16206020023800326Mark David Bode0023800326True
Allergan plchttps://pcaobus.org/form-ap-filings/1113/1113Allergan plc11133/3/2017 8:25:52 AM2016ea45dc6b-63ff-4b93-b491-32978c9dbcc0238PricewaterhouseCoopers LLP560985Allergan plc1578845AGN; AGN.PA0023800326Mark David Bode0023800326True